City
Epaper

COVID-19 vaccine inequity 'catastrophic moral failure', says WHO

By ANI | Updated: March 23, 2021 02:35 IST

Michael Ryan, Executive Director of World Health Organisation (WHO) Health Emergencies Program, said on Monday that the "inequitable" COVID-19 vaccine distribution was a "catastrophic moral failure" and a "failed opportunity."

Open in App

Michael Ryan, Executive Director of World Health Orgsation (WHO) Health Emergencies Program, said on Monday that the "inequitable" COVID-19 vaccine distribution was a "catastrophic moral failure" and a "failed opportunity."

Speaking at a virtual press conference from Geneva on Monday about the recent rise of cases in Europe -- up by "12 percent" in the last week -- Ryan stressed that there was no "golden solution" to end the pandemic.

He said that many countries have the strategy to "get enough vaccine" and "push enough vaccine to people," assuming that the COVID-19 pandemic would be shaken off with vaccine rollouts.

"I am sorry, it is not(the case)," he said. "There are not enough vaccines in the world, and they are distributed terribly iniquitously."

"In fact, we have missed a huge opportunity to bring vaccines on board as a comprehensive measure," said Ryan. "It is not only a catastrophic moral failure, but it is (also) an epidemiologic failure."

Global infections rose up in the last week. Among the most affected places was South Asia, which saw a surge of 49 percent in the number of cases, with India taking the bulk of the rise. Another hotspot was Western Pacific, with the Philippines and Papua New Guinea accounting for most of the 29 percent increase.

Meanwhile, the gap in vaccine procurement between richer and poorer countries "is growing every single day," warned Tedros Adhanom Ghebreyesus, Director-General of the WHO, at Monday's press conference.

As the world is struggling to contain the pandemic, vaccination is underway in an increasing number of countries with the already-authorised coronavirus vaccines.

Meanwhile, 264 candidate vaccines are still being developed worldwide -- 82 of them in clinical trials -- in countries including Germany, China, Russia, Britain, and the United States, according to the latest information released by the World Health Orgzation. (/Xinhua)

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: World health orgsationWorld health orgzationMichael ryanasiaGeneva
Open in App

Related Stories

MumbaiMumbai’s Efforts Lead to UN’s Permanent Consumer Protection Mechanism in Geneva

HealthCovid-19 Surge In Asia: Could the JN.1 Variant Spark a Global Resurgence?

NashikNashik Resident’s Mahalaxmi Decor Features Impressive Collection of Global Currencies (See Pics)

BusinessBloodbath on Asian Indices, Markets in Red Amid Bank of Japan’s Rate Hike and Yen Appreciation

NashikNashik: Ashoka Group of Schools Becomes First in India to Participate in UN Event in Geneva

International Realted Stories

International"Created special identity in Dubai through hard work, culture, values": MP CM Yadav lauds Indian diaspora

InternationalDhaka: CNG drivers block Banani roads as a sign of protest

InternationalDubai: Consul General Sivan meets MP CM Mohan Yadav ahead of investment outreach

InternationalSouth Korea: Medical students announce return to school after 17-month boycott

InternationalAxiom-4 splash down on July 15 at 3 pm: Jitendra Singh on Shubhanshu Shukla's return